Department of Radiology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.
Cardiovasc Intervent Radiol. 2010 Aug;33(4):787-93. doi: 10.1007/s00270-009-9770-9. Epub 2009 Dec 5.
The purpose of this study was to retrospectively determine the local control rate and contributing factors to local progression after computed tomography (CT)-guided radiofrequency ablation (RFA) for unresectable lung tumor. This study included 138 lung tumors in 72 patients (56 men and 16 women; age 70.0 +/- 11.6 years (range 31-94); mean tumor size 2.1 +/- 1.2 cm [range 0.2-9]) who underwent lung RFA between June 2000 and May 2009. Mean follow-up periods for patients and tumors were 14 and 12 months, respectively. The local progression-free rate and survival rate were calculated to determine the contributing factors to local progression. During follow-up, 44 of 138 (32%) lung tumors showed local progression. The 1-, 2-, 3-, and 5-year overall local control rates were 61, 57, 57, and 38%, respectively. The risk factors for local progression were age (>or=70 years), tumor size (>or=2 cm), sex (male), and no achievement of roll-off during RFA (P < 0.05). Multivariate analysis identified tumor size >or=2 cm as the only independent factor for local progression (P = 0.003). For tumors <2 cm, 17 of 68 (25%) showed local progression, and the 1-, 2-, and 3-year overall local control rates were 77, 73, and 73%, respectively. Multivariate analysis identified that age >or=70 years was an independent determinant of local progression for tumors <2 cm in diameter (P = 0.011). The present study showed that 32% of lung tumors developed local progression after CT-guided RFA. The significant risk factor for local progression after RFA for lung tumors was tumor size >or=2 cm.
本研究旨在回顾性确定 CT 引导下射频消融(RFA)治疗不可切除肺部肿瘤后局部控制率和局部进展的相关因素。该研究纳入了 72 名患者(56 名男性和 16 名女性)共 138 个肺部肿瘤,年龄 70.0±11.6 岁(范围 31-94 岁);平均肿瘤大小 2.1±1.2cm(范围 0.2-9cm),这些患者均在 2000 年 6 月至 2009 年 5 月期间接受了肺部 RFA 治疗。患者和肿瘤的中位随访时间分别为 14 个月和 12 个月。计算局部无进展生存率和总生存率,以确定局部进展的相关因素。随访期间,138 个肺部肿瘤中有 44 个(32%)出现局部进展。1、2、3 和 5 年总局部控制率分别为 61%、57%、57%和 38%。局部进展的危险因素为年龄(≥70 岁)、肿瘤大小(≥2cm)、性别(男性)和 RFA 时未达到卷边(P<0.05)。多因素分析发现肿瘤大小≥2cm 是局部进展的唯一独立因素(P=0.003)。对于肿瘤直径<2cm 的患者,68 例中有 17 例(25%)出现局部进展,1、2 和 3 年的总局部控制率分别为 77%、73%和 73%。多因素分析发现,年龄(≥70 岁)是肿瘤直径<2cm 患者局部进展的独立决定因素(P=0.011)。本研究表明,CT 引导下 RFA 治疗后 32%的肺部肿瘤出现局部进展。RFA 治疗肺部肿瘤后局部进展的显著危险因素是肿瘤直径≥2cm。